Aliases & Classifications for Endophthalmitis

MalaCards integrated aliases for Endophthalmitis:

Name: Endophthalmitis 12 56 52 42 14 69

Classifications:

MalaCards categories:
Global: Rare diseases
Anatomical: Eye diseases
Orphanet: 56  
Rare eye diseases


External Ids:

Disease Ontology 12 DOID:4692
MeSH 42 D009877
NCIt 47 C34586
Orphanet 56 ORPHA199323
MESH via Orphanet 43 D009877
UMLS via Orphanet 70 C0014236
ICD10 via Orphanet 34 H44.0 H44.1
ICD10 33 H45.1
UMLS 69 C0014236

Summaries for Endophthalmitis

Disease Ontology : 12 A globe disease that is characterized by inflammation of the inside of the eye.

MalaCards based summary : Endophthalmitis is related to purulent endophthalmitis and acute endophthalmitis, and has symptoms including redness or discharge of eye An important gene associated with Endophthalmitis is DEFB1 (Defensin Beta 1), and among its related pathways/superpathways are Development VEGF signaling via VEGFR2 - generic cascades and Fluid shear stress and atherosclerosis. The drugs Cefazolin and Lidocaine have been mentioned in the context of this disorder. Affiliated tissues include eye, endothelial and liver, and related phenotype is neoplasm.

Wikipedia : 72 Endophthalmitis is an inflammation of the interior of the eye. It is a possible complication of all... more...

Related Diseases for Endophthalmitis

Diseases in the Endophthalmitis family:

Chronic Endophthalmitis Acute Endophthalmitis

Diseases related to Endophthalmitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 171)
id Related Disease Score Top Affiliating Genes
1 purulent endophthalmitis 33.4 PLG VEGFA
2 acute endophthalmitis 12.1
3 chronic endophthalmitis 12.1
4 phacoanaphylactic uveitis 11.1
5 hodgkin's lymphoma, nodular sclerosis 10.6 ICAM1 SELE
6 lymphomatous thyroiditis 10.6 ICAM1 SELE
7 marginal corneal ulcer 10.6 ICAM1 SELE
8 tick paralysis 10.6 ICAM1 SELE
9 cysticercosis 10.6 ICAM1 SELE
10 macular dystrophy, atypical vitelliform 10.6 HMGB1 PRF1
11 inferolateral myocardial infarct 10.6 ICAM1 SELE
12 moved to 244450 10.6 ICAM1 SELE
13 riboflavin transporter deficiency 10.5 ICAM1 SELE
14 clear cell adenocarcinoma of ovary 10.5 DEFB1 VEGFA
15 dermatomycosis 10.5 ICAM1 SELE
16 craniopharyngioma 10.5 ICAM1 SELE
17 rheumatic myocarditis 10.5 DEFB1 SELE
18 bowman's membrane folds or rupture 10.5 DEFB1 PLG
19 waterhouse-friderichsen syndrome 10.5 SELE VEGFA
20 cataract 10.5
21 dracunculiasis 10.5 ICAM1 SELE
22 dysphagia 10.4 ICAM1 SELE
23 sympathetic ophthalmia 10.4
24 ventricular extrasystoles with syncope, perodactyly, and robin sequence 10.4 OPTN VEGFA
25 central epithelioid sarcoma 10.4 MRAP PRF1
26 conduct disorder 10.4 ICAM1 SELE
27 congenital ichthyosiform erythroderma 10.4 OPTN VEGFA
28 lobomycosis 10.3 ICAM1 SELE
29 erythema elevatum diutinum 10.3 MRAP VEGFA
30 leukodystrophy, hypomyelinating, 5 10.3 MRAP VEGFA
31 colorectal adenoma 10.3 PLG VEGFA
32 iliac vein thrombophlebitis 10.3 PLG VEGFA
33 lichen planus 10.3 ICAM1 VEGFA
34 cryptosporidiosis 10.3 PLG VEGFA
35 phlegmonous dacryocystitis 10.2 ICAM1 SELE VEGFA
36 skin granular cell tumor 10.2 MRAP OPTN
37 tick-borne encephalitis 10.2 ICAM1 SELE
38 pneumonia 10.2
39 turner syndrome 10.1 PLG SELE
40 angiomyoma 10.1 MRAP PLG
41 retinitis 10.1
42 autoimmune hepatitis 10.1 ICAM1 SELE VEGFA
43 keratitis 10.0
44 hyperaldosteronism 10.0 ICAM1 MRAP VEGFA
45 uveitis 10.0
46 endotheliitis 10.0
47 vernal conjunctivitis 10.0 ICAM1 PLG VEGFA
48 hypopyon 10.0
49 meningitis 10.0
50 cellulitis 10.0

Graphical network of the top 20 diseases related to Endophthalmitis:



Diseases related to Endophthalmitis

Symptoms & Phenotypes for Endophthalmitis

UMLS symptoms related to Endophthalmitis:


redness or discharge of eye

MGI Mouse Phenotypes related to Endophthalmitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 neoplasm MP:0002006 9.02 GON4L ICAM1 PLG PRF1 VEGFA

Drugs & Therapeutics for Endophthalmitis

Drugs for Endophthalmitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 192)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Cefazolin Approved Phase 4 25953-19-9 656510 33255
2
Lidocaine Approved, Vet_approved Phase 4 137-58-6 3676
3
Ephedrine Approved Phase 4,Phase 2 299-42-3 9294
4
Estradiol Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2 50-28-2 5757
5
Ethinyl Estradiol Approved Phase 4,Phase 3,Phase 2 57-63-6 5991
6
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2 354812-41-2, 151096-09-2 152946
7
Norgestimate Approved Phase 4,Phase 3,Phase 2 35189-28-7 6540478
8
Pseudoephedrine Approved Phase 4,Phase 2 90-82-4 7028
9
Methylprednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 83-43-2 6741
10
Prednisolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 50-24-8 5755
11
Triamcinolone Approved, Vet_approved Phase 4,Phase 1,Phase 2 124-94-7 31307
12
Povidone Approved Phase 4 9003-39-8
13 Povidone-iodine Approved Phase 4 25655-41-8
14
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
15
Glycerol Approved, Investigational Phase 4 56-81-5 753
16
Loteprednol Approved Phase 4 82034-46-6, 129260-79-3 444025 9865442
17
Levofloxacin Approved, Investigational Phase 4 100986-85-4 149096
18
Ofloxacin Approved Phase 4 82419-36-1 4583
19
Bevacizumab Approved, Investigational Phase 4,Phase 2,Phase 3 216974-75-3
20
Ranibizumab Approved Phase 4,Phase 3,Phase 2,Phase 1 347396-82-1 459903
21
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
22
Hyaluronic acid Approved, Vet_approved Phase 4 9004-61-9 53477741 24759
23
Iodine Investigational Phase 4 7553-56-2 807
24 Anesthetics Phase 4
25 Anesthetics, Local Phase 4
26 Anti-Arrhythmia Agents Phase 4
27 Anti-Bacterial Agents Phase 4,Phase 3,Phase 2,Phase 1
28 Antibiotics, Antitubercular Phase 4,Phase 3,Phase 2,Phase 1
29 Anti-Infective Agents Phase 4,Phase 3,Phase 2,Phase 1
30 Antitubercular Agents Phase 4,Phase 3
31 Central Nervous System Depressants Phase 4
32 Cephalosporins Phase 4
33 Diuretics, Potassium Sparing Phase 4
34 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2
35 Pharmaceutical Solutions Phase 4,Phase 3,Phase 2
36 Sodium Channel Blockers Phase 4
37 Autonomic Agents Phase 4,Phase 2
38 Contraceptive Agents Phase 4,Phase 3,Phase 2
39 Contraceptives, Oral Phase 4,Phase 3,Phase 2
40 Contraceptives, Oral, Combined Phase 4,Phase 3,Phase 2
41 Estradiol 17 beta-cypionate Phase 4,Phase 3,Phase 2
42 Estradiol 3-benzoate Phase 4,Phase 3,Phase 2
43 Estradiol valerate Phase 4,Phase 3,Phase 2 979-32-8
44 Fluoroquinolones Phase 4,Phase 3,Phase 2
45 Nasal Decongestants Phase 4,Phase 2
46 Norgestimate, ethinyl estradiol drug combination Phase 4,Phase 3,Phase 2
47 Nucleic Acid Synthesis Inhibitors Phase 4,Phase 3,Phase 2,Phase 1
48 Ophthalmic Solutions Phase 4,Phase 3,Phase 2,Phase 1
49 Polyestradiol phosphate Phase 4,Phase 3,Phase 2
50 Respiratory System Agents Phase 4,Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 104)

id Name Status NCT ID Phase Drugs
1 Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain Unknown status NCT02324166 Phase 4 Cefazolin;Lidocaine
2 Dosage Study for Vigamox Eye Drops Prior to Intravitreal Injections Unknown status NCT00690313 Phase 4 Vigamox
3 IntraVitreal Triamcinolone Acetonide: Preventing Raised Eye-pressure by Tracking Elevations After Topical Steroids Unknown status NCT00744666 Phase 4 Prednisolone 1% topical eye drops
4 Prophylaxis of Acute Post-Traumatic Bacterial Endophthalmitis Completed NCT00398658 Phase 4 gentamycin and clindamycin
5 Povidone-iodine Antisepsis for Strabismus Surgery Completed NCT00461656 Phase 4 Preoperative conjunctival irrigation with 5% or 1.25% PI
6 The Utility of in Vivo Confocal Microscopy to Assess Cellular Response and Efficacy of Long-term Topical Steroid Treatment in Patients With Dry Eye Disease Completed NCT02120079 Phase 4 Lotemax;Artificial Tears
7 Comparative Efficacy of Different Regimens of PVPI 5% Eye Drops Instillation in Reducing Conjunctival Bacterial Flora Completed NCT01739920 Phase 4
8 Effectiveness of Topical 0.5% Levofloxacin to Reduce the Conjunctival Bacterial Flora Before Intraocular Surgery Completed NCT00491049 Phase 4 0.5% levofloxacin eye drops
9 Aurolab Hydrophobic Foldable Intraocular Lens Study Completed NCT00449267 Phase 4
10 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4 Aflibercept
11 Bromfenac Versus Dexamethasone After Cataract Surgery Recruiting NCT03317847 Phase 4 Bromfenac 0.09 % Ophthalmic Solution;Dexamethasone 0.1% ophthalmic suspension
12 Evaluation of the Effect of Intravitreal Injections of Anti-VEGF on Macular Perfusion in Diabetic Patients Using OCTA Recruiting NCT03246152 Phase 4 Bevacizumab
13 Hyaluronic Acid Gels for Upper Lid Retraction in Active Stage Thyroid Eye Disease Recruiting NCT01738243 Phase 4 Hyaluronic Acid Gel injection;Saline injection
14 Influence of Diabetes Control on Treatment of Diabetic Macular Edema With Ranibizumab Recruiting NCT02665689 Phase 4 ranibizumab
15 Frozen Versus Fresh Corneal Carriers for the Boston KPro Type I Donor Carriers Enrolling by invitation NCT01950598 Phase 4
16 Fluconazole Versus Micafungin for Candida Bloodstream Infection in Non-Neutropenic Patients Withdrawn NCT00304772 Phase 4 Fluconazole;Micafungin
17 Interest of Intravitreal Corticotherapy as the First-line Treatment for Post-operative Endophthalmitis Unknown status NCT01768078 Phase 3
18 The Safety and Efficacy of a Tumor Necrosis Factor Receptor Fusion Protein on Uveitis Associated With Juvenile Rheumatoid Arthritis Unknown status NCT00012506 Phase 3 TNFR:Fc
19 Endophthalmitis Vitrectomy Study (EVS) Completed NCT00000130 Phase 3 Intravitreal Antibiotics
20 Clinical Trial of Eye Prophylaxis in the Newborn Completed NCT00000120 Phase 3 Erythromycin Ointment;Silver Nitrate Drops
21 Retaane® in Age-Related Macular Degeneration Completed NCT00569569 Phase 2, Phase 3 juxtascleral depot injection of Retaane
22 Systemic Avastin Therapy in Age-Related Macular Degeneration Completed NCT00531024 Phase 2, Phase 3 Bevacizumab;Sodium Chloride
23 Effect of Intravitreal Ranibizumab Injection With Retinal Vein Occlusion (RVO) Completed NCT00942864 Phase 3 ranibizumab
24 Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis Completed NCT00884585 Phase 3 Cyclosporine Vehicle;Cyclosporine 0.010%
25 Evaluation of Efficacy and Safety of Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis. Recruiting NCT02770729 Phase 3 Moxifloxacin;No injection of moxifloxacin
26 A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behcet's Disease Active, not recruiting NCT02307513 Phase 3 Apremilast (CC-10004);Placebo
27 Safety and Efficacy of Intracameral Zimoxin for Prevention of Endophthalmitis After Cataract Surgery Not yet recruiting NCT03244072 Phase 2, Phase 3 Moxifloxacin;Placebo
28 Intracameral Antibiotic Safety Study Not yet recruiting NCT02590523 Phase 3 Vancomycin;Moxifloxacin;Placebo
29 Evaluate Azithromycin Plus Chloroquine And Sulfadoxine Plus Pyrimethamine Combinations For Intermittent Preventive Treatment Of Falciparum Malaria Infection In Pregnant Women In Africa Terminated NCT01103063 Phase 3 Azithromycin plus chloroquine;sulfadoxine-pyrimethamine
30 The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy Unknown status NCT00849537 Phase 1, Phase 2 Triamcinolone
31 Safety Study of Conventional Versus Micropulse Transscleral Cyclophotocoagulation in Treating End-Stage Glaucoma Unknown status NCT00349414 Phase 1, Phase 2
32 TNRF:Fc to Treat Eye Inflammation in Juvenile Rheumatoid Arthritis Completed NCT00001862 Phase 2 Enbrel
33 Modified Intraocular Lens to Reduce Eye Inflammation After Cataract Surgery in Uveitis Patients Completed NCT00001311 Phase 2
34 Combination Ranibizumab and Bromfenac for Neovascular Age-related Macular Degeneration Completed NCT00805233 Phase 2 combination ranibizumab + bromfenac;ranibizumab injection alone
35 Ranibizumab and Reduced Fluence PDT for AMD Completed NCT00527475 Phase 2 ranibizumab;verteporfin
36 Leflunomide to Treat Uveitis Completed NCT00001863 Phase 2 Leflunomide
37 HAT in Eye Complications of Behcet's Disease Completed NCT00001865 Phase 2 Daclizumab
38 Daclizumab to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00070759 Phase 2 Daclizumab
39 Daclizumab Injections to Treat Non-Infectious Sight-Threatening Uveitis Completed NCT00043667 Phase 2 Daclizumab
40 RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery Completed NCT02065375 Phase 2 RTA 408 0.5% Ophthalmic Suspension;RTA 408 1.0% Ophthalmic Suspension;Placebo
41 Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis Completed NCT01789320 Phase 1, Phase 2 triamcinolone acetonide (Triesence®)
42 Safety and Efficacy of AIN457 in Noninfectious Uveitis Completed NCT00685399 Phase 2 AIN457;AIN 457;AIN457
43 Intracameral Moxifloxacin for Prevention of Postcataract Endophthalmitis Recruiting NCT02595359 Phase 2 Moxifloxacin
44 Ustekinumab (STELARA ) for the Treatment of Active Sight-Threatening Uveitis Recruiting NCT02911116 Phase 2 Ustekinumab
45 Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar Keratoplasty Not yet recruiting NCT02424006 Phase 1, Phase 2
46 Tocilizumab in the Management of Juvenile Idiopathic Arthritis Associated Uveitis Terminated NCT01603355 Phase 1, Phase 2 Tocilizumab
47 Treatment of Non-infectious Intermediate and Posterior Uveitis Associated Macular Edema With Intravitreal Methotrexate Terminated NCT01314417 Phase 1, Phase 2 Methotrexate
48 Sub-Tenon's Injection of Triamcinolone and Ciprofloxacin in a Controlled-Release System for Cataract Surgery Terminated NCT00431028 Phase 1, Phase 2
49 Ustekinumab for Active Sight-Threatening Uveitis Withdrawn NCT01647152 Phase 1, Phase 2 Ustekinumab
50 Lucentis for New Onset Neovascular Glaucoma Withdrawn NCT00727038 Phase 1, Phase 2 Ranibizumab (Lucentis)

Search NIH Clinical Center for Endophthalmitis

Cochrane evidence based reviews: endophthalmitis

Genetic Tests for Endophthalmitis

Anatomical Context for Endophthalmitis

MalaCards organs/tissues related to Endophthalmitis:

39
Eye, Endothelial, Liver, Testes, Thyroid, Lung, Retina

Publications for Endophthalmitis

Articles related to Endophthalmitis:

(show top 50) (show all 838)
id Title Authors Year
1
Successful management of post-traumatic vancomycin-resistant enterococcus endophthalmitis. ( 28848938 )
2017
2
EXOGENOUS MENINGOCOCCAL ENDOPHTHALMITIS: A CASE REVIEW. ( 28850051 )
2017
3
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231). ( 27993282 )
2017
4
Endophthalmitis Following Strabismus Surgery: IPOSC Global Study. ( 28925741 )
2017
5
Favorable Outcome in Coccidioides Endophthalmitis-A Combined Medical and Surgical Treatment Approach. ( 28872517 )
2017
6
Clinical Features and Visual Acuity Outcomes in Culture-Positive Endogenous Fungal Endophthalmitis in Southern China. ( 28884023 )
2017
7
Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure. ( 28225198 )
2017
8
The Susceptibility of Bacterial Endophthalmitis Isolates to Vancomycin, Ceftazidime, and Amikacin: a 23 Year-Review. ( 28845474 )
2017
9
Endophthalmitis associated with Purpureocillium lilacinum during infliximab treatment for surgically induced necrotizing scleritis, successfully treated with 27-gauge vitrectomy. ( 28429128 )
2017
10
Endogenous Fungal Endophthalmitis: An Increasing Problem Among Intravenous Drug Users. ( 28829854 )
2017
11
Predictors of visual outcome and the role of early vitrectomy in Streptococcal endophthalmitis. ( 28949429 )
2017
12
Successful treatment of fungal endophthalmitis using intravitreal caspofungin. ( 28832730 )
2017
13
Listeria Monocytogenes Endophthalmitis after Intermediate Uveitis and ppV for Retinal Detachment. ( 28329887 )
2017
14
Re: Javitt JC: Intracameral antibiotics reduce the risk of endophthalmitis after cataract surgery: does the preponderance of the evidence mandate a global change in practice? (Ophthalmology 2016;123:226-231). ( 27993280 )
2017
15
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia. ( 28872724 )
2017
16
Comment on "Surgical management of fungal endophthalmitis resulting from fungal keratitis". ( 28944212 )
2017
17
MALDI-TOF mass spectrometry for rapid diagnosis of postoperative endophthalmitis. ( 27989942 )
2017
18
Re: Jabbarvand etA al.: Endophthalmitis occurring after cataract surgery: outcomes of more than 480 000 cataract surgeries, epidemiologic features, and risk factors (Ophthalmology 2016;123:295-301). ( 27993276 )
2017
19
Safety and efficacy of intracameral moxifloxacin injection for prophylaxis of endophthalmitis after phacoemulsification. ( 28832735 )
2017
20
Perioperative antibiotics for prevention of acute endophthalmitis after cataract surgery. ( 28192644 )
2017
21
360 Degree Deep Corneal Vascularization In A Case Of Endophthalmitis With Corneal Abscess. ( 28718272 )
2017
22
In response to: "Ranjan, P, Joshi P, and Gupta M. Staphylococcus aureus induced endogenous endophthalmitis with pink hypopyon." ( 28448724 )
2017
23
Feline-transmitted Staphylococcal hyicus endophthalmitis after clear lens extraction: a case report. ( 28860868 )
2017
24
Endophthalmitis Due to Proteus vulgaris after Pars Plana Vitrectomy with Devastating Outcome. ( 28936060 )
2017
25
POSTOPERATIVE ENDOPHTHALMITIS CAUSED BY BOSEA THIOOXIDANS. ( 28925927 )
2017
26
RESOLUTION OF TREATMENT-RESISTANT SUBRETINAL FLUID IN A PATIENT WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION FOLLOWING ENDOPHTHALMITIS. ( 28925926 )
2017
27
Re: Haripriya etA al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: an analysis of 600a88000 surgeries (Ophthalmology. 2017;124:768-775). ( 28938934 )
2017
28
Acute endophthalmitis after cataract surgery: 164 consecutive cases treated at a referral center in South Korea. ( 28548647 )
2017
29
BLEB-RELATED ENDOPHTHALMITIS AFTER USE OF THE INVITRIA INJECTION GUIDE. ( 28858192 )
2017
30
Re: Haripriya etA al.: Endophthalmitis reduction with intracameral moxifloxacin prophylaxis: analysis of 600 000 surgeries (Ophthalmology. 2017;124:768-775). ( 28823359 )
2017
31
Comparison of methods for identifying causative bacterial microorganisms in presumed acute endophthalmitis: conventional culture, blood culture, and PCR. ( 28222703 )
2017
32
UTILITY OF INTRAOPERATIVE OPTICAL COHERENCE TOMOGRAPHY IN ACUTE ENDOPHTHALMITIS. ( 28858193 )
2017
33
Liver Abscess and Metastatic Endophthalmitis Secondary to Klebsiella pneumoniae K1. ( 28050045 )
2017
34
Chronic mucocutaneous candidiasis presenting as Candida endophthalmitis. ( 27085277 )
2016
35
Correction for Pradeep et al., Draft Genome Sequence of Elizabethkingia anopheles, Isolated from a Postoperative Endophthalmitis Patient. ( 27932658 )
2016
36
Microbial profile of the vitreous aspirates in culture proven exogenous endophthalmitis: A 10-year retrospective study. ( 27080765 )
2016
37
Endophthalmitis caused by Acinetobacter spp. as the presenting manifestation of diabetes mellitus. ( 27579461 )
2016
38
Endophthalmitis prophylaxis in cataract surgery: Overview of current practice patterns around the world. ( 27981903 )
2016
39
Post-cataract surgery endophthalmitis: Brief literature review. ( 27579452 )
2016
40
Possible Relation between Lack of Posterior Vitreous Detachment and Severe Endogenous Endophthalmitis. ( 27766175 )
2016
41
Endophthalmitis Prophylaxis Using a Single Drop of Thermoresponsive Controlled-Release Microspheres Loaded with Moxifloxacin in a Rabbit Model. ( 27933222 )
2016
42
Chronic post-operative iris prosthesis endophthalmitis in a patient with traumatic aniridia: a case report. ( 27829389 )
2016
43
Aspergillus fumigatus Endophthalmitis with Necrotizing Scleritis following Pars Plana Vitrectomy. ( 27379189 )
2016
44
Endophthalmitis after cataract surgery: epidemiology, risk factors, and evidence on protection. ( 27661662 )
2016
45
Brown Heroin-Associated Candida albicans Ventriculitis and Endophthalmitis Treated with Voriconazole. ( 27504092 )
2016
46
Out of Sight: Culture-Negative Endocarditis and Endophthalmitis. ( 27637598 )
2016
47
Posttraumatic Endophthalmitis in children: Epidemiology, Diagnosis, Management, and Prognosis. ( 27929716 )
2016
48
Endophthalmitis or toxic anterior segment syndrome? ( 27515565 )
2016
49
25-GAUGE TROCAR CANNULA FOR ACUTE ENDOPHTHALMITIS-RELATED IN-OFFICE VITREOUS TAP AND INJECTION: Patient Comfort and Physician Ease of Use. ( 27471824 )
2016
50
Endogenous Fusarium Endophthalmitis in Diabetes Mellitus. ( 27990307 )
2016

Variations for Endophthalmitis

Expression for Endophthalmitis

Search GEO for disease gene expression data for Endophthalmitis.

Pathways for Endophthalmitis

GO Terms for Endophthalmitis

Cellular components related to Endophthalmitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cell surface GO:0009986 9.26 HMGB1 ICAM1 PLG VEGFA
2 extracellular space GO:0005615 9.1 DEFB1 HMGB1 ICAM1 PLG SELE VEGFA

Biological processes related to Endophthalmitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 ovarian follicle development GO:0001541 9.37 ICAM1 VEGFA
2 response to hypoxia GO:0001666 9.33 ICAM1 NARFL VEGFA
3 positive chemotaxis GO:0050918 9.32 HMGB1 VEGFA
4 leukocyte cell-cell adhesion GO:0007159 9.26 ICAM1 SELE
5 positive regulation of receptor internalization GO:0002092 8.96 SELE VEGFA
6 endothelial cell chemotaxis GO:0035767 8.62 HMGB1 VEGFA

Molecular functions related to Endophthalmitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 chemoattractant activity GO:0042056 8.62 HMGB1 VEGFA

Sources for Endophthalmitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....